EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Computer-Aided Drug Design for Type 2 Diabetes-Related Enzymes: SILCS-Based Fragment Mapping, Pharmacophore Modeling, and Virtual Screening

Esmat Mohammadi iD, Justin A Lemkul iD

Journal of Chemical Information and Modeling · 2026

DOI: 10.1021/acs.jcim.6c01733 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Chemical Information and Modeling, 2026. Verfasst von Esmat Mohammadi und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemical Engineering, Virginia Tech, Blacksburg, Virginia24061, United States. Hauptthemen laut MEDLINE: Drug Design, Diabetes Mellitus, Type 2, Computer-Aided Design, alpha-Glucosidases. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Institute of Food and Agriculture, NIGMS NIH HHS, Division of Materials Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Highly charged enzyme active sites present a challenge for conventional Site Identification by Ligand Competitive Saturation (SILCS) because strongly interacting charged probes can suppress sampling of neutral fragments, while additive force fields do not explicitly account for electronic polarization. To address these limitations, we developed a comprehensive SILCS-based computational framework and applied it to the N-terminal and C-terminal domains of maltase–glucoamylase and to α-amylase. Both the conventional mixed-probe SILCS workflow and a modified neutral–charged protocol were evaluated using the CHARMM additive and Drude polarizable force fields. FragMap convergence analysis demonstrated reliable sampling across all systems, with the neutral–charged protocol alleviating competitive exclusion effects observed in conventional simulations. In highly charged catalytic pockets, the conventional workflow was dominated by cationic probe sampling, suppressing neutral and hydrogen-bonding features. Separation of charged and neutral probes restored chemically diverse interaction patterns, improving representation of hydrogen-bond donor, acceptor, and hydrophobic hotspots. Incorporation of the Drude polarizable force field further enhanced resolution of electrostatic and hydrogen-bonding interactions. Energy-based SILCS-Pharmacophore models were generated from the neutral–charged FragMaps and used for virtual screening of the Maybridge and ChemBridge libraries. Hits were refined using SILCS-MC, ranked by ligand grid free energy (LGFE) and ligand efficiency (LE), and analyzed through scaffold- and fingerprint-based clustering. Integration of energetic and structural analyses enabled identification of favorable scaffolds and functional group patterns associated with strong binding efficiency. Together, this study develops, evaluates, and applies an improved SILCS workflow to three enzymes associated with type 2 diabetes (T2D), demonstrating its utility for characterizing highly charged active sites and prioritizing candidate inhibitors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drug DesignDiabetes Mellitus, Type 2Computer-Aided Designalpha-Glucosidasesalpha-AmylasesPharmacophoreLigandsCatalytic DomainDrug Evaluation, PreclinicalHumansModels, Molecular

Substanzen

Ligandsalpha-Glucosidasesalpha-Amylases

Autor:innen und Institutionen

  • Department of Chemical Engineering, Virginia Tech, Blacksburg, Virginia24061, United States.
  • Department of Biochemistry, Virginia Tech, Blacksburg, Virginia24061, United States.
  • Center for Computer-Aided Drug Design, Virginia Tech, Blacksburg, Virginia24061, United States.

ORCID-Profile: Esmat Mohammadi, Justin A Lemkul

Förderung

  • National Institute of Food and Agriculture
  • NIGMS NIH HHS
  • Division of Materials Research
  • GlycoMIP
  • National Institute of General Medical Sciences

Zitieren

APA

Mohammadi, E., & Lemkul, J. A. (2026). Computer-Aided Drug Design for Type 2 Diabetes-Related Enzymes: SILCS-Based Fragment Mapping, Pharmacophore Modeling, and Virtual Screening. Journal of Chemical Information and Modeling. https://doi.org/10.1021/acs.jcim.6c01733

Vancouver

Mohammadi E, Lemkul JA. Computer-Aided Drug Design for Type 2 Diabetes-Related Enzymes: SILCS-Based Fragment Mapping, Pharmacophore Modeling, and Virtual Screening. Journal of Chemical Information and Modeling. 2026. doi:10.1021/acs.jcim.6c01733

BibTeX
@article{Mohammadi2026,
  author = {Mohammadi, Esmat and Lemkul, Justin A},
  title = {Computer-Aided Drug Design for Type 2 Diabetes-Related Enzymes: SILCS-Based Fragment Mapping, Pharmacophore Modeling, and Virtual Screening},
  journal = {Journal of Chemical Information and Modeling},
  year = {2026},
  doi = {10.1021/acs.jcim.6c01733}
}
Kostenlos starten →